NASDAQ: SURG
Last close prices updated as of
Mar 21, 2023, 4:00 PM EST
| USD | BATS BZX Real-Time Price
- Last Close 4.08
- Sector Technology
- Industry Software - Application
- Investment Style Small Value
- Day Range 3.88 – 4.13
- Year Range 3.21 – 7.61
- Market Cap 56.4306 Mil
- Volume / Avg 940.0 / 88,254.0
- Price / Sales 0.46
- Price / Book 89.35
- Forward Div Yield —
- Trailing Div Yield —
Morningstar‘s Stock Analysis SURG
Valuation
Currency in —
Is it the right time to buy or sell?
Is it the right time to buy or sell?
1-Star Price
INVESTOR
5-Star Price
INVESTOR
Economic Moat
INVESTOR
About Quantitative Ratings
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Unlock Our Full Analysis With Morningstar Investor
Company Profile SURG
Business Description
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Surge Blockchain and Other; Surge Logics; TW and ECS (Electronic Check Services). The Company's blockchain platform utilizes a suite of financial and prepaid products to convert corner stores into tech hubs for underbanked neighbourhoods. The neighbourhood stores are profit partners that provide a multichannel distribution network for SurgePays.
FAQs for Surgepays Inc Stock
No. SURG does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks,
to compare the relationship between a stock’s price and how it rewards stockholders through dividends.
The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
SURG’s market cap is 56.43 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares.
It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the
largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.
Learn more about market capitalization.
SURG’s stock style is Small Value.
Style is an investment factor that has a meaningful impact on investment risk and returns.
Style is calculated by combining value and growth scores, which are first individually calculated.
High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.
Learn more about style.
SURG’s price/sales is 0.46.
Price/sales represents the amount an investor is willing to pay for a dollar generated from
a particular company’s sales or revenues.
SURG’s price/forward earnings is 34.01.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates.
The lower the Forward P/E, the cheaper the stock.
SURG’s price/book is 89.35.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets,
based on historical, rather than current, valuations. Historical valuations generally do not reflect
a company’s current market value. Value investors frequently look for companies that have low price/book ratios.
See SURG’s valuation ratios compared to the Market Index.
SURG’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare SURG’s historical performance against its industry peers and the overall market.